Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain

Annals of Neurology

Volumn 57, Issue 1, 2005, Pages 50-59

  Felderhoff Mueser, Ursula ^a,c   Sifringer, Marco ^a   Polley, Oliver ^a   Dzietko, Mark ^a   Leineweber, Birgit ^a   Mahler, Lieselotte ^a   Baier, Michael ^b   Bittigau, Petra ^a   Obladen, Michael ^a   Ikonomidou, Chrysanthy ^a   Bührer, Christoph ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN INJURY; CELL DEATH; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; HYPEROXIA; HYPOTHESIS; IATROGENIC DISEASE; NERVE CELL; NERVE FUNCTION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONCENTRATION; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CASPASE 1; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; OXYGEN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 19944426265     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20322     Document Type: Article

References (40)

1. Bregman J. Developmental outcome in very low birthweight infants. Current status and future trends. Pediatr Clin North Am 1998;45:673-690.
2. Tin W, Wariyar U, Hey E. Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. Northern Neonatal Network. Br Med J 1997;314:107-111.
3. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-1226.
4. Saugstad OD. Is oxygen more toxic than currently believed? Pediatrics 2001;108:1203-1205.
5. Hoehn T, Felderhoff-Mueser U, Maschewski K, et al. Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain. Pediatr Res 2003;54:179-184.
6. Felderhoff-Mueser U, Bittigau P, Sifringer M, et al. Oxygen causes cell death in the developing brain. Neurobiol Dis 2004;17:273-282.
7. Rozycki HJ, Comber PG, Huff TF. Cytokines and oxygen radicals after hyperoxia in preterm and term alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002;282: L1222-L1228.
8. Pierce BT, Napolitano PG, Pierce LM, et al. The effects of hypoxia and hyperoxia on fetal-placental vascular tone and inflammatory cytokine production. Am J Obstet Gynecol 2001;185:1068-1072.
9. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744.
10. Suzuki N, Suzuki S, Duncan GS, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002;416:750-756.
11. Reznikov LL, Kim SH, Westcott JY, et al. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proc Natl Acad Sci USA 2000;97:2174-2179.
12. Rabuffetti M, Sciorati C, Tarozzo G, et al. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci 2000;20:4398-4404.
13. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002;67:161-172.
14. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
15. Yatsiv I, Morganti-Kossmann MC, Perez D, et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab 2002;22:971-978.
16. Hedtjarn M, Leverin AL, Eriksson K, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002;22:5910-5919.
17. Taglialatela G, Perez-Polo JR, Rassin DK. Induction of apoptosis in the CNS during development by the combination of hyperoxia and inhibition of glutathione synthesis. Free Radic Biol Med 1998;25:936-942.
18. De Olmos JS, Ingram WR. The projection field of the stria terminalis in the rat brain. An experimental study. J Comp Neurol 1972;146:303-334.
19. Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000;874:123-130.
20. West MJ, Gundersen HJ. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990;296:1-22.
21. Bittigau P, Sifringer M, Pohl D, et al. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 1999;45:724-735.
22. Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000-2003.
23. Liu XH, Kwon D, Schielke GP, et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999;19:1099-1108.
24. Xu H, Barks JD, Schielke GP, Silverstein FS. Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme. Brain Res Mol Brain Res 2001;90:57-67.
25. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-609.
26. Cai Z, Pan ZL, Pang Y, et al. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64-72.
27. Dommergues MA, Patkai J, Renauld JC, et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000;47:54-63.
28. Pang Y, Cai Z, Rhodes PG. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 2003;140:205-214.
29. Jander S, Schroeter M, Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb Blood Flow Metab 2002;22:62-70.
30. Dinarello CA. Interleukin-18 and the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 2004;30:417-434, ix.
31. Suzuki N, Chen NJ, Millar DG, et al. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J Immunol 2003;170:4031-4035.
32. Lee JK, Kim SH, Lewis EC, et al. Differences in signaling pathways by IL-lbeta and IL-18. Proc Natl Acad Sci USA 2004;101:8815-8820.
33. Wald D, Commane M, Stark GR, Li X. IRAK and TAK1 are required for IL-18-mediated signaling. Eur J Immunol 2001;31:3747-3754.
34. Harris C, Maroney AC, Johnson EM, Jr. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J Neurochem 2002;83:992-1001.
35. Takeda K, Ichijo H. Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells 2002;7:1099-1111.
36. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-675.
37. Minagawa K, Tsuji Y, Ueda H, et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 2002;17:164-170.
38. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 2001;50:712-719.
39. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79-83.
40. Nishida A, Misaki Y, Kuruta H, Takashima S. Developmental expression of copper, zinc-superoxide dismutase in human brain by chemiluminescence. Brain Dev 1994;16:40-43.